A study published in Brain ... such as MRI, CT, and laboratory tests to rule out reversible causes. However, these methods do not identify typical pathologic changes such as beta-amyloid plaques ...

People with a low level of LDL, the bad cholesterol, have a lower risk of dementia — both stroke dementia and Alzheimer’s ...

The global Positron Emission Tomography (PET) market is set to witness a growth rate of 5% in the next 5 years. Growing ...

Group sales grew by 6%1 at constant exchange rates (CER; 7% in CHF), driven by high demand for newer medicines and diagnostic solutions.Pharmaceuticals Division sales rose by 8% (9% in CHF) on continu ...

Dementia is a disease that I fear that my family will get older or I will come to myself. Dementia is a degenerative disease ...

and beta-amyloid protein.6–10 A blood assay using GFAP and UCH-L1 has Food and Drug Administration approval to evaluate the requirement for a CT scan and rule out haemorrhagic pathology in traumatic ...

In a plenary session at the annual American Academy of Neurology meeting, Paul Edison, MD, PhD, of Imperial College London in England, assessed how GLP-1 receptor agonists might influence cognitive ...

A phase I/II trial showed that transplanting dopaminergic progenitors derived from induced pluripotent stem cells was safe in ...

Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related to Alzheimer's disease in individuals with mild cognitive impairment ...

Life Molecular Imaging (LMI) and PharmaLogic Holdings Corp. (PharmaLogic), a world-class contract development and manufacturing organization (CDMO) and radiopharmacy solutions provider, announce the ...

In addition to Alzheimer's, the research explored how human microglia respond in models of brain cancer and multiple sclerosis. In both cases, the engineered cells adopted unique gene expression ...